OR WAIT null SECS
© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
David J. Calkins, PhD, is Assistant Vice President for Research at Vanderbilt University Medical Center and Chair of the Glaucoma Research Foundation Research Committee and the Catalyst for a Cure Advisory Board.
July 13, 2021
New strategies are needed to rethink how we treat glaucoma to do more than just manage eye pressure—to actually restore vision by promoting the survival of retinal ganglion cells and their axons.